Human galanin expresses amphipathic properties that modulate its vasoreactivity in vivo

[1]  T. Bártfai,et al.  Galanin—A neuropeptide with inhibitory actions , 1995, Cellular and Molecular Neurobiology.

[2]  Vladimir P. Torchilin,et al.  Polyethylene Glycol-Diacyllipid Micelles Demonstrate Increased Accumulation in Subcutaneous Tumors in Mice , 2002, Pharmaceutical Research.

[3]  H. Onyuksel,et al.  Mechanistic Studies on Surfactant-Induced Membrane Permeability Enhancement , 2000, Pharmaceutical Research.

[4]  Hideyuki Suzuki,et al.  Development of a Novel Bioactive Formulation of Vasoactive Intestinal Peptide in Sterically Stabilized Liposomes , 1997, Pharmaceutical Research.

[5]  R. Dey,et al.  Origin of galanin in nerves of cat airways and colocalization with vasoactive intestinal peptide , 1993, Cell and Tissue Research.

[6]  I. Rubinstein,et al.  A Novel Formulation of VIP in Sterically Stabilized Micelles Amplifies Vasodilation In Vivo , 2004, Pharmaceutical Research.

[7]  I. Rubinstein,et al.  Phospholipids modulate the biophysical properties and vasoactivity of PACAP-(1--38). , 2002, Journal of applied physiology.

[8]  I. Rubinstein,et al.  Interactions of human secretin with sterically stabilized phospholipid micelles amplify peptide-induced vasodilation in vivo , 2002, Peptides.

[9]  I. Rubinstein,et al.  Secretin self-assembles and interacts spontaneously with phospholipids in vitro , 2002, Peptides.

[10]  A. Burlet,et al.  Galanin receptor antagonists decrease fat preference in Brattleboro rat , 2002, Neuropharmacology.

[11]  B. Mayer,et al.  Nitric oxide-containing neurons in the bovine gut, with special reference to their relationship with VIP and galanin. , 2000, Archives of histology and cytology.

[12]  T. Branchek,et al.  Galanin receptor subtypes. , 2000, Trends in pharmacological sciences.

[13]  S. Dagar,et al.  Surface-active properties of vasoactive intestinal peptide☆ , 2000, Peptides.

[14]  Manisha Patel,et al.  Conformation and vasoreactivity of VIP in phospholipids: effects of calmodulin☆ , 1999, Peptides.

[15]  J. Crawley.  The role of galanin in feeding behavior , 1999, Neuropeptides.

[16]  F. Pierau,et al.  Inhibitory modulation of cutaneous vascular responses by endogenous galanin in the pigeon , 1999, Neuroscience Letters.

[17]  M. El-Salhy.  Neuroendocrine peptides in stomach and colon of an animal model for human diabetes type I. , 1999, Journal of diabetes and its complications.

[18]  E. Daniel,et al.  Colocalization of Inhibitory Mediators, NO, VIP and Galanin, in Canine Enteric Nerves , 1998, Peptides.

[19]  T. Bártfai,et al.  Purification of a galanin degrading 70 kDa metallo-peptidase from bovine spinal cord , 1998, Neuropeptides.

[20]  Manisha Patel,et al.  Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[21]  T. Bártfai,et al.  NMR study of the conformation and localization of porcine galanin in SDS micelles. Comparison with an inactive analog and a galanin receptor antagonist. , 1998, Biochemistry.

[22]  C. Franklin,et al.  Peptidergic control of gastrointestinal blood flow in the estuarine crocodile, Crocodylus porosus. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[23]  I. Rubinstein,et al.  Stabilization of vasoactive intestinal peptide by lipids. , 1998, The Journal of pharmacology and experimental therapeutics.

[24]  F. Pierau,et al.  Evidence for an inhibition by endogenous galanin of neurogenic cutaneous vasodilatation in the pigeon , 1998, Neuroscience Letters.

[25]  A. Sgoifo,et al.  Effects of Galanin and the Galanin Receptor Antagonist Galantide on Plasma Catecholamine Levels during a Psychosocial Stress Stimulus in Rats , 1998, Neuroendocrinology.

[26]  I. Rubinstein,et al.  Mechanisms of vasodilation elicited by VIP in sterically stabilized liposomes in vivo. , 1997, The American journal of physiology.

[27]  N. Yanaihara,et al.  Role of N-terminal active sites of galanin in neurally evoked circular muscle contractions in the guinea-pig ileum. , 1997, European journal of pharmacology.

[28]  T. Bártfai,et al.  Galanin receptors: involvement in feeding, pain, depression and Alzheimer's disease. , 1997, Life sciences.

[29]  G. Luc,et al.  Interstitial fluid apolipoprotein A-II: an association with the occurrence of myocardial infarction. , 1996, Atherosclerosis.

[30]  J. Crawley.  Galanin-acetylcholine interactions: Relevance to memory and Alzheimer's disease , 1996 .

[31]  G. P. Courtice,et al.  Vasoconstrictor effects of galanin and distribution of galanin containing fibres in three species of elasmobranch fish , 1995, Regulatory Peptides.

[32]  C. Olopade,et al.  Short-term exposure to lipopolysaccharide is associated with microvascular contractile dysfunction in vivo. , 1995, Life sciences.

[33]  W. Mayhan,et al.  L-arginine dilates cheek pouch arterioles in hamsters with hereditary cardiomyopathy but not in controls. , 1995, The Journal of laboratory and clinical medicine.

[34]  I. Rubinstein,et al.  Vasoactive intestinal peptide encapsulated in liposomes: effects on systemic arterial blood pressure. , 1994, Life sciences.

[35]  D. McCloskey,et al.  Galanin antagonist effects on cardiac vagal inhibitory actions of sympathetic stimulation in anaesthetized cats and dogs. , 1993, The Journal of physiology.

[36]  T. Bártfai,et al.  The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion. , 1992, European journal of pharmacology.

[37]  H. Harling,et al.  Circulating galanin: origin, metabolism, and pharmacokinetics in anesthetized pigs. , 1992, The American journal of physiology.

[38]  V. Pieribone,et al.  M-15: high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. Ignarro,et al.  Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP. , 1987, The American journal of physiology.

[40]  H. Lithell,et al.  Lipoprotein composition of human suction-blister interstitial fluid. , 1987, Journal of lipid research.

[41]  C. Wahlestedt,et al.  Galanin: neuromodulatory and direct contractile effects on smooth muscle preparations , 1985, British journal of pharmacology.